| DC Field | Value | Language |
|---|
| dc.contributor.author | Mereuta, Ion | |
| dc.contributor.author | Valica, Vladimir | |
| dc.contributor.author | Parii, Sergiu | |
| dc.contributor.author | Carauş, Vladimir | |
| dc.contributor.author | Clecicov, Marta | |
| dc.contributor.author | Svet, Veronica | |
| dc.contributor.author | Cernat, Mircea | |
| dc.date.accessioned | 2019-06-26T07:03:15Z | |
| dc.date.available | 2019-06-26T07:03:15Z | |
| dc.date.issued | 2016 | |
| dc.identifier.issn | 1810-3936 | |
| dc.identifier.uri | http://www.ionmereuta.md/files/Info-28-1.pdf | |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/5632 | |
| dc.description | Simpozion Naţional de Oncologie cu participare internaţională „Vigilenţa oncologică în activitatea medicală, depistarea precoce şi tratamentul tumorilor” dedicat aniversării de 40 ani de activitate a Catedrei de Oncologie, Hematologie şi Radioterapie a USMF “N. Testemiţanu”, Clinica Oncologie Generală şi Mamologie, IP USMF „Nicolae Testemiţanu”, Centrul Ştiinţific al Medicamentului (CSM)al IP USMF „Nicolae Testemiţanu”, SC ”CSK Grup Plus” SRL, Chişinău, Republica Moldova | en_US |
| dc.description.abstract | Summary: It is studied the Flamen indigenous combined medical substance 100 ml oral emulsion
containing the active ingredients glycine and dihidroquercitina. In General Oncology Clinic and the IP
Mammology Medical University “Nicolae Testemitanu” clinical trial was conducted according to the
principles of good practice in research involving breast cancer and cancer of the reproductive organs.
It was determined that 100ml of Flamen is harmless, easy to administer and is recommended for those
suffering from malignancies as adjuvant radiotherapy after polichymioterapy. It is considered to have
antyoxydant effects, liver, immune stimulator and detoxifier. | en_US |
| dc.language.iso | ro | en_US |
| dc.publisher | Revista ştiinţifico-practică "Info-Med" | en_US |
| dc.subject | Flamena - pharmacology | en_US |
| dc.subject | Inoffensivity | en_US |
| dc.subject | Reproductive Organs | en_US |
| dc.subject | Clinical Randomized Study | en_US |
| dc.subject | Base Therapy | en_US |
| dc.subject.mesh | Breast Neoplasms - drug therapy | en_US |
| dc.subject.mesh | Genital Neoplasms, Female - therapy | en_US |
| dc.subject.mesh | Emulsions | en_US |
| dc.subject.mesh | Glycine - analogs and derivatives | en_US |
| dc.subject.mesh | Antioxidants - therapeutic use | en_US |
| dc.subject.mesh | Efficiency | en_US |
| dc.subject.mesh | Immunity | en_US |
| dc.title | Rezultatele cercetarii clinice: studiul proprietăţilor citoprotectoare (chimio, radioprotectoare) a emulsiei orale Flamena 100 ml la pacientele cu cancer mamar şi cancerul organelor reproductive supuse chimiosau radioterapiei | en_US |
| dc.title.alternative | The results of clinical researches: the study of cytoprotective properties (chemo- /radioprotective) of Flamena 100 ml oral emulsion at pacients diagnosed with breast cancer and reproductive organs who undergo chemo- or radiotherapy | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | ARTICOLE ȘTIINȚIFICE
|
